Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway

Fig. 2

Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in vitro. a IC50 of CDDP in the indicated cells. b Annexin V-FITC and PI staining of the indicated cells treated with cisplatin (10 μM) for 24 h. Each bar represents the mean ± SD of three independent experiments. c Representative micrographs (left) and quantification of Tunel positive signaling in the indicated assay. * P < 0.05. d Western blotting analysis of cleaved caspase3 and PARP in the indicated cells. α-tubulin was used as a loading control

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us